Cannabis Legislation Sees Mixed Results During Oregon’s 2026 Legislative Session
SALEM, Ore. — Oregon lawmakers considered several cannabis-related measures during the 2026 legislative session, but only one bill ultimately reached Governor Tina Kotek’s desk and became law.
The session featured three major pieces of cannabis legislation: Senate Bill 1548, House Bill 4139, and House Bill 4142. While all three bills underwent significant amendments during the legislative process, only House Bill 4142 successfully navigated both chambers and was signed into law.
Packaging and Labeling Bill Advances but Stalls in House
Senate Bill 1548, introduced by the Senate Committee on Early Childhood and Behavioral Health and championed by Senator Lisa Reynolds, sought to impose new packaging and labeling requirements on retail cannabis products.
Among its provisions, the bill would have required cannabis edibles to be individually wrapped and limited to no more than 10 milligrams of THC per serving. The proposal generated considerable debate among industry stakeholders.
The legislation was opposed by the Cannabis Industry Association of Oregon (CIAO), which argued that the requirements would increase costs and create unnecessary burdens for cannabis businesses. Despite that opposition, SB 1548 cleared committee and passed the Senate on a 22–5 vote.
After being referred to the House Committee on Economic Development, Small Business, and Trade, the bill received a public hearing on February 20, 2026, followed by a work session two days later. The measure ultimately remained in committee when the Legislature adjourned.
Omnibus Cannabis Bill Narrowed Before Moving Forward
House Bill 4139 was introduced as a broad cannabis omnibus measure intended to address concerns raised by multiple stakeholders.
As originally drafted, the bill included increased quarterly funding for enforcement efforts targeting illegal cannabis cultivation operations. It also created a definition for industrial hemp-derived cannabinoid products and proposed a tax on those products when sold through Oregon Liquor and Cannabis Commission (OLCC) licensed retail stores.
Additionally, the bill sought to expand Oregon’s definition of a “debilitating medical condition” to include medical conditions that an attending healthcare provider determines may be mitigated through the medical use of marijuana.
During the legislative process, HB 4139 was significantly narrowed. The final version retained provisions increasing enforcement funding and expanding the definition of debilitating medical conditions. The bill passed committee and was referred to the Joint Committee on Ways and Means, where it remained upon adjournment.
Ryan’s Law Expands Cannabis Access in Hospice and Residential Care
The session’s most significant cannabis-related success came with House Bill 4142,
commonly known as “Ryan’s Law.”
Introduced by Representatives Farrah Chaichi and Thuy Tran and Senator Floyd Prozanski, and seventeen cosponors, the legislation was designed to improve access to medical cannabis for individuals receiving hospice, palliative, and long-term residential care. Governor Kotek signed the bill into law on April 7, 2026.
HB 4142 builds upon existing Oregon Medical Marijuana Program (OMMP) provisions that allow patients to designate a hospice, palliative care organization, or residential care facility as an organizational caregiver. Under the new law, facilities must permit the use of medical cannabis on their premises and develop written policies governing its
use.
The legislation also establishes educational requirements for facility staff. Training must include cannabis pharmacology, dosing strategies, delivery methods such as edibles, extracts, and vaporized products, as well as potential contraindications and interactions with other medications.
Supporters view the measure as an important step toward integrating cannabis education into Oregon’s healthcare system and improving patient-centered care for individuals facing serious illness or end-of-life conditions.
Advocates say the law provides patients with another option for symptom management beyond traditional opioid-based treatments. For some patients, medical cannabis may offer relief while allowing them to remain more engaged with family and loved ones during long-term or end-of-life care.
Looking Ahead
Although only one cannabis bill ultimately became law during the 2026 session, the measures considered by lawmakers reflected a growing shift in Oregon’s cannabis policy discussions. Issues ranging from product regulation and enforcement funding to healthcare integration and patient access continue to shape the future of cannabis
policy in the state.
With federal recognition of cannabis as a medicine continuing to evolve and Oregon policymakers preparing for the 2027 legislative session, many expect conversations surrounding medical cannabis, healthcare integration, patient protections, and program modernization to remain at the forefront of future legislative efforts.